Search

everythinglearnresearchcommunity

for

Search:↓

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

A woman with severe angioedema improved significantly after treatment with rituximab.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Six months after COVID-19, most patients still had autoantibodies.

The treatment was effective for lupus nephritis with manageable side effects.

Cyclosporine A slowly changes cell membranes, explaining some of its effects and side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

The model and estimator can predict drug exposure in kidney transplant patients well.

Dengue symptoms and liver issues can persist for over two months, especially in men.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Tofacitinib is an effective and safe treatment for alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Long COVID can cause long-lasting symptoms, but vaccination and early treatment can help prevent it.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.